Zhittya Genesis Medicine Announces: Free Zoom Webinar: Zhittya’s Parkinson’s Disease Research Study: 6-Month Patient Follow-Up Report
Zhittya Genesis Medicine Inc. First-in-man study of FGF-1 in the brain with a new intranasal treatment for Parkinson’s disease LAS VEGAS, Dec. 19 2022 (GLOBE NEWSWIRE) — Zhittya Genesis Medicine, Inc. (a private company) (“Zhittya”), announced that they will host a webinar on Tuesday, December 20, 2022 at 4:00 p.m. PT / 7:00 p.m. EST, …